Back
AbbVie, Inc. Vs. Bristol Myers Squibb Co. Industry Stock Comparison
Buy
59
ABBV
AbbVie, Inc.
Last Price:
$229.79
Seasonality Move:
0.29%
Buy
74
BMY
Bristol Myers Squibb Co.
Last Price:
$54.23
Seasonality Move:
14.3%
Buy
59
AbbVie, Inc. (ABBV)
is a Buy
Is AbbVie, Inc. a Buy, Sell or Hold?
-
The current AbbVie, Inc. [ABBV] share price is $229.74. The Score for ABBV is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
-
ABBV is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
74
Bristol Myers Squibb Co. (BMY)
is a Buy
Is Bristol Myers Squibb Co. a Buy, Sell or Hold?
-
The current Bristol Myers Squibb Co. [BMY] share price is $54.21. The Score for BMY is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.
-
BMY is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ABBV Stock Price Chart
What is AbbVie, Inc.'s stock price today?
-
The AbbVie, Inc. share price today is $229.74Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ABBV is experiencing slight selling pressure.
BMY Stock Price Chart
What is Bristol Myers Squibb Co.'s stock price today?
-
The Bristol Myers Squibb Co. share price today is $54.21The current trend is moderately bullish and BMY is experiencing slight buying pressure.
ABBV Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.76 | Buy |
| Relative Strength Index (14 RSI): | 54.97 | Buy |
| Chaikin Money Flow: | -313366 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (224.11 - 229.65) | Buy |
| Bollinger Bands (100): | (212.54 - 231.88) | Buy |
BMY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.64 | Buy |
| Relative Strength Index (14 RSI): | 65.28 | Buy |
| Chaikin Money Flow: | 2760708 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (49.82 - 54.26) | Buy |
| Bollinger Bands (100): | (44.3 - 50.68) | Buy |
ABBV Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 228.35 | Buy |
| 20-day SMA: | 226.51 | Buy |
| 50-day SMA: | 226.77 | Buy |
| 200-day SMA: | 205.99 | Buy |
| 8-day EMA: | 228.73 | Buy |
| 20-day EMA: | 227.54 | Buy |
| 50-day EMA: | 225.93 | Buy |
| 200-day EMA: | 210.44 | Buy |
BMY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 54.27 | Sell |
| 20-day SMA: | 52.83 | Buy |
| 50-day SMA: | 48.91 | Buy |
| 200-day SMA: | 48.59 | Buy |
| 8-day EMA: | 54.09 | Buy |
| 20-day EMA: | 52.73 | Buy |
| 50-day EMA: | 50.15 | Buy |
| 200-day EMA: | 49.12 | Buy |
AbbVie, Inc. Earnings Growth & ABBV Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.29 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.61 per share, and an increase next year of $1.59 per share.
Bristol Myers Squibb Co. Earnings Growth & BMY Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.54 per share, and a decrease next year of $0.15 per share.
AbbVie, Inc. Technical Analysis
| Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Bristol Myers Squibb Co. Technical Analysis
| Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||